Searchable abstracts of presentations at key conferences in endocrinology

ea0047oc4 | Spotlight on Neuroendocrine tumours | Theranostics2016

68Ga, 64Cu labelling and affinity study of NODAGANOC, a NODAGA conjugated somatostatin analogue

Azzouna Rana Ben , Al-Shoukr Faisal , Hyafil Fabien , Rouzet Francois , Guilloteau Denis , Le Guludec Dominique

Introduction: DOTANOC is a largely used somatostatin analogue in NETs investigations. In NODAGANOC, the DOTA is replaced by NODAGA, a chelator derivative from NOTA which is the ‘gold standard’ for Ga3+ and Cu2+ chelation because it forms more stable complexes than DOTA.[1] The aim of our study is to evaluate the affinity of NODAGANOC for somatostatin receptors (sst) and to develop a 68Ga and 64Cu labelled NODAGANOC for a fu...

ea0044p59 | Bone and Calcium | SFEBES2016

Primary hyperparathyroidism and concomitant vitamin D deficiency: Study of diagnosis and management outcomes

Khan Uzma , Al-Sharefi Ahmed , Partha Praveen , Kamaruddin Shafie , Tarigopula Giridhar , Peter Paul

Introduction: Primary hyperparathyroidism (PHPT) is the third most common endocrine disorder; its evaluation includes biochemical investigations and imaging studies prior to surgical intervention. Imaging is advised as an aide to surgery and not for diagnostic purposes. Coexistence of PHPT and vitamin D deficiency is common; however, the exact nature of the relationship (causal vs secondary) is not clear.Subject and methods: We conducted a retrospective ...

ea0042p32 | (1) | Androgens2016

Differential expression and androgen regulation of microRNA molecules in breast cancer cells

Ahram Mamoun , Zaza Rand , Mustafa Ebtihal , Jarrar Heba , Al-Saber Razan , Hammad Shatha Abu , Zihlif Malek

MicroRNA molecules (miRNAs) have important roles in regulating cell behavior. In addition, their expression levels can be used in tumor classification. The expression of miRNAs has been to be regulated by the androgen receptor (AR), which seems to play an interesting role in the tumorigenic process of breast cancer. We hypothesized that AR may control the behavior of breast cancer cells via modulating the expression of miRNAs. Using PCR arrays, we examined the differential exp...

ea0041ep264 | Clinical case reports - Pituitary/Adrenal | ECE2016

The endocrine trifecta: rarer presentation of a rare disease

Khan Uzma , Al-Sharefi Ahmed , Peter Paul , Kamaruddin Shafie , Tarigopula Giridhar , Partha Praveen

Introduction: Autoimmune polyendocrine syndrome type 2 is a rare disease characterized by the presence of autoimmune Addison’s disease in combination with thyroid autoimmune disease and/or type 1 diabetes mellitus, and possible occurrence of other autoimmune non-endocrine disorders. The combination of the three glands diseases is even rarer and is referred to as Carpenter’s syndrome.A long time interval is often present between the manifestatio...

ea0059p076 | Clinical practice, governance & case reports | SFEBES2018

Outcomes of endoscopic surgical intervention for acromegaly – the Wessex experience

Curtis Louise , Mathad N , Chakraborty Aabir , Brewster Sarah , Millar Kate , Parsad Meenakshi , Al-Mrayat Ma'en

Background: Transsphenoidal surgery is the primary therapy in majority of Acromegaly patients with GH-secreting somatotroph adenomas. Reported outcomes of surgery show an initial remission rate of 40–50% for macroadenomas and >85% for microadenomas. Rates of hypopituitarism following endoscopic pituitary decompression vary between 5 and 25%. Invasion of cavernous sinus indicates the tumour is unlikely to be resectable.Methods: We audited the res...

ea0059ep53 | Clinical practice, governance & case reports | SFEBES2018

Case Report: The experience of using Etomidate in the management of severe Cushing’s disease and MRSA bacteraemia in a district general hospital in the United Kingdom

Wong Stephanie , Yap Yew Wen , Narayanan Prakash , Daousi Christina , Al-Jubouri Mohammad , Mahgoub Yahya

Background: The management of Cushing’s disease can be challenging especially when patients can present with sepsis and severely immunocompromised with limited oral medications to achieve cortisol control. We review a case of Cushing’s disease and the medical management of Cushing’s disease.Case Report: A 54 year old female presented with symptomatic hyperglycaemia with truncal obesity, proximal muscle weakness, right posterior thorax haem...

ea0059ep72 | Neuroendocrinology and pituitary | SFEBES2018

Carcinoid heart disease as the presentation of ovarian neuroendocrine tumour (NET) in the absence of liver metastases

Arambewela Maulee , Al-Mukhtar Ahmed , Macdonald Madeleine , Denis Andrew , O'toole Laurence , Munir Alia

Ovarian neuroendocrine tumours are rare (< 2% gynaecological tumours) and first described in 1939 by Stewart et al. The occurrence of carcinoid heart disease alongside this is anecdotal. We present a previously fit 66 year old female, with a 6 month history of shortness of breath and ankle oedema. Echocardiogram revealed severe fixed tricuspid regurgitation, pulmonary valve disease, dilated right heart chambers and preserved left ventricular function. Carcinoid heart disea...

ea0038p355 | Reproduction | SFEBES2015

Vitamin D regulates extravillous trophoblast migration by inhibiting sphingosine-1-phosphate (S1P) signalling via S1P receptor 2

Johnstone Edward , Al-Saghir Khiria , Tan Cherlyn , Adlam Daman , Westwood Melissa

Failure of trophoblast invasion and remodelling of maternal blood vessels leads to the pregnancy complication pre-eclampsia (PE). Metabolomic profiling of placentas from such pregnancies has identified deranged sphingolipid metabolism as one of the pathways altered in PE. In other systems, the bioactive sphingolipid, sphingosine-1-phosphate (S1P) controls cell migration therefore this study aimed to determine its effect on extravillous trophoblast (EVT) function.<p class="...

ea0037ep181 | Reproduction, endocrine disruptors and signalling | ECE2015

Ameliorated effects of allium sativum against bisphenol A-induced reproductive toxicity in male rats

Yousef Mokhtar Ibrahim , Newairy Al-Sayeda A , Salama Afrah F , Saber Shaimaa E M

There is growing evidence that bisphenol A (BPA) may adversely affect humans. BPA is an endocrine disruptor that has been shown to be harmful in laboratory animal studies. A comprehensive literature search found 91 studies linking BPA to human health; 53 published within the last year. This body of literature is showing associations between BPA exposure and adverse perinatal, childhood, and adult health outcomes, including reproductive and developmental effects, metabolic dise...